TFN Reader Grapevine: There’s Something about Viral Genetics, Inc. (VRAL)
Today's Financial News - Posted August 25, 2009
Recent activity surrounding biotech penny stock Viral Genetics, Inc. (OTC:VRAL) indicates this company could be ready for a boost
by J. Christoph Amberger
Baltimore, MD — TFN: TFN eNews reader Cliff X. filed the following with us this afternoon:
“Viral Genetics, Inc. (OTC:VRAL) is a small company that develops and commercializes a series of proteins based primarily on thymus nuclear protein (TNP). These relate to combatting infectious diseases, such as HIV/AIDS, other autoimmune conditions and immunological deficiency.
“Rumor has it that they are planning something big - heard about them filing with the FDA re: investigatory new drug filing within the month.
“Right now, it’s just speculation, but apparently others may know more than me, as the stock started flying today around mid-afternoon. I was lucky enough to get into it at $0.495. Maybe your other members would be interested.”
I bet they are, Cliff!
I have a hard time believing VRAL traded almost 31Million shares today on that one post trigger rumouring an FDA application!
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM